The promoter has requested the board of directors of the Claris Lifesciences to consider and approve the delisting proposal in accordance with the regulations.
Further, the RBI said the investment limit by NRIs has gone up to 24 percent from the existing 10 percent.
The US-FDA started a surprise audit of the manufacturing site of Claris Lifesciences last week. The site, located near Ahmedabad, was sold to global drug maker Baxter as part of a broader USD 625 million deal.
The company said it will discuss with its advisors and identify the most efficient method of transferring a significant majority of the net proceeds to its shareholder
The foreign institutional investors (FIIs)/foreign portfolio investors (FPIs) in Fortis Healthcare Ltd has crossed the overall limit of 24 per cent of its paid-up capital, The Reserve Bank of India said.
Hindalco | Inox Leisure | Tata Motors | Hero Motocorp | SML Isuzu | Quess Corp and Vakrangee are stocks, which are in news today.
Claris Lifesciences Ltd today said its consolidated net profit jumped by 233 per cent at Rs 35 crore in Q3 FY2017 as against Rs 15 crore in the corresponding period of last year.
On February 8, 2017 Copthall Mauritius Investment Limited sold 7,19,433 shares of Claris Lifesciences at Rs 313.
Claris Lifesciences | Aurobindo Pharma | Jagran Prakashan | Sical Logistics and Bharat Financial Inclusion, are stocks which are in news today.
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today.
SP Tulsian of sptulsian.com tells CNBC-TV18 why he would prefer to avoid Titagarh Wagons for now. He also shares his outlook on Claris Lifesciences after it sold off its injectibles business and on the cement sector.
CNBC-TV18's Ekta Batra lists out stocks that you should focus on – Aurobindo Pharma, Hindalco, BPCL, UltraTech Cement, Axis Bank, TCS, Claris Life.
Here are a few top buzzing stocks picked by CNBC-TV18's analysts in trade today -- Claris Life, J&K Bank, Sun and Aurobindo Pharma, Treehouse Nursery.
Claris Lifesciences shares hit a record high of Rs 430.10, up 20 percent intraday Friday after the company sold its injectable business to US healthcare company.
Manchanda said he would like to hear from the management with regard to the distribution of the proceeds of the deal. If Claris' management decides to delist the company, it may opt for a share buyback as dividend payout involves distribution tax, he added.
Axis Bank | IL&FS Transportation Networks | Saksoft | Avantel | Ram Informatics | Dilip Buildcon | Cox & Kings | Zee Media | Jagran Prakashan | Somany Ceramics | Godawari Power and Ispat | Majesco | Jammu & Kashmir Bank | Claris Life and Sical Logistics are stocks, which are in the news today.
Pharmaceutical Company Claris Lifesciences has sold its injectibles business to the US based Baxter. The deal is priced at USD 625 million and will be completed by the second half of 2017.
Mahindra & Mahindra | DLF | SAIL | NHPC | Puravankara | MMTC | Claris Life | Jindal Steel | Electrosteel Steels | Time Technoplast | Ujjivan Financial | Banco Products | Monnet Ispat | Mindtree and Usher Agro are stocks, which are in the news today.
On October 24, 2016 Everest Finance And Investment Company bought 2,89,789 shares of Claris Lifesciences at Rs 270.
Some of the stocks that should be on your radar are: Vedanta, Cairn India, Tata Steel, Adani Enterprises, Adani Power, Coal India, Mahindra CIE Automotive, Reliance Communications, Reliance Capital, National Aluminium Company, Claris Lifesciences, Torrent Pharmaceuticals, Mahindra & Mahindra Financial Services.
Tata Steel | Sun Pharma | Wipro | Cairn | Vedanta | Motherson Sumi | Claris Life | Reliance Capital | Reliance Defence | Mahindra CIE | Coal India | Amtek Auto | Godfrey Phillips | Alok Industries | Gitanjali Gems | Nalco | Setco Auto | NHPC | Sicagen India and Nandan Denim are stocks, which are in the news today.
Indian pharmaceutical companies Aurobindo and Intas are among the final contenders for Teva‘s generic drug business in UK. The strategy will help the companies expand their European business.
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have - GMR Infrastructure, Adani Enterprises, Tata Motors, Claris Lifesciences and Shree Renuka Sugars.
"Wholly owned subsidiary Claris Injectables has received five 483s during the inspection on the plant 1 - Clarion 1," the Ahmedabad-headquartered pharma company in its filing on August 26.
Some of the stocks that should be on your radar are: Tata Motors, Infosys, Aurobindo Pharma, Claris Lifesciences, GMR Infrastructure, Future Retail.